focus -WSS

focus

author：focus 2025-10-01 15:28:28 - browse：6

Buildings like hospitals and banks on a web with people operating laptops and phones — health tech coverage from STAT — Adobe

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug.

But just because it was simple didn’t mean it was going to work.

The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel treatments. Even after hitting roadblock after roadblock, the company stuck to its original plan and ended up vaporizing over $400 million in investment before finally throwing in the towel.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： BMI, flaws aside, is found to be useful estimate of body fat in youth

Wikipedia

WSS

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

The Pandemic Treaty must support building strong health systems

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Study: Black kids more likely to die after surgery than white kids

ASCO: Palliative care found as helpful given virtually as in person

Scientific mystery highlights the blind spots in genomics databases

focus

focus

knowledge

Peter Hotez and the public health issue of online harassment

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Psychedelics group wrestles with new pharma identity

BMI, flaws aside, is found to be useful estimate of body fat in youth

Medicare proposal to cover medical devices draws a mixed reaction

At ASCO, AstraZeneca reports strong data for breast cancer drug

Supreme Court strikes down use of affirmative action

Republican states more likely to report Covid vaccine side effects

Dobbs anniversary: the lost opportunity of abortion as health care

Pancreatic cancer is often deadly, but new discoveries are raising hope

focus

Harvard scientists, with Google, unveil the most detailed brain map ever

With trial win, GSK could get blood cancer drug back on market

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Woman returns to dialysis after doctors remove transplanted pig kidney

At ASCO, AstraZeneca reports strong data for breast cancer drug

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Wikipedia

entertainment

knowledge

hotspot